Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Abstract
Renalase
, a novel amine oxidase, is mainly expressed in the kidney, heart, and skeletal muscle. It has been known to degrade circulating catecholamines and plays a crucial role in human diseases. Recent studies have demonstrated its structure, unique bioactivities, function, and the gene polymorphisms in human diseases. In this review, we summarize the effects of
renalase
on hypertension,
myocardial ischemia
, acute kidney injury (AKI), ischemic stroke, cardiac dysfunction, organ transplantation, and diabetes mellitus reported in numerous studies.
...
PMID:Renalase, a new secretory enzyme: Its role in hypertensive-ischemic cardiovascular diseases. 2476 61
Ischaemia/reperfusion (I/R) injury will cause additional death of cardiomyocytes in
ischaemic heart disease
. Recent studies revealed that
renalase
was involved in the I/R injury. So, the myocardial tissue-specific knockdown mouse models were needed for the investigations of
renalase
. To establish the mouse models, intramyocardial injection of siRNAs targeting
renalase
was performed in mice. The wild distribution and high transfection efficiency of the siRNAs were approved. And the
renalase
expression was efficiently suppressed in myocardial tissue. Compared with the high cost, time consumption, and genetic compensation risk of the Cre/loxP technology, RNA interference (RNAi) technology is much cheaper and less time-consuming. Among the RNAi technologies, injection of siRNAs is safer than virus. And considering the properties of the I/R injury mouse models, the efficiency and durability of injection with siRNAs are acceptable for the studies. Altogether, intramyocardial injection of siRNAs targeting
renalase
is an economical, safe, and efficient method to establish myocardial tissue-specific
renalase
knockdown mouse models.
...
PMID:Intramyocardial Injection of siRNAs Can Efficiently Establish Myocardial Tissue-Specific Renalase Knockdown Mouse Model. 2786 59